Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanespimycin Rollover Study for Advanced Malignancies
NCT00779428Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2006
- Primary completion
- Mar 2013
- Countries
- 1
01
Overview
A Phase 2 trial of tanespimycin in malignant neoplasms (advanced stage), sponsored by Bristol Myers Squibb. Started Jul 2006; status: completed.
02
Drugs
tanespimycin
03
Conditions
malignant neoplasms (advanced stage)
Beyond the preview
Go deeper on NCT00779428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00779428.